• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera

tetano

Editor, Senior Moderator
Clin Infect Dis. 2017 Mar 23. doi: 10.1093/cid/cix269. [Epub ahead of print]
[h=1]Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera.[/h] Xie H[SUP]1[/SUP], Li L[SUP]2[/SUP], Ye Z[SUP]1[/SUP], Li X[SUP]1[/SUP], Plant EP[SUP]1[/SUP], Zoueva O[SUP]1[/SUP], Zhao Y[SUP]1[/SUP], Jing X[SUP]1[/SUP], Lin Z[SUP]1[/SUP], Kawano T[SUP]1[/SUP], Chiang MJ[SUP]1[/SUP], Finch CL[SUP]1[/SUP], Kosikova M[SUP]1[/SUP], Zhang A[SUP]1[/SUP], Zhu Y[SUP]1[/SUP], Wan XF[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background.:[/h] Effectiveness of seasonal influenza vaccines mainly depends upon how well vaccine strains represent circulating viruses; mismatched strains can lead to reduced protection. Human have complex influenza exposure histories that increase with age, which may lead to different post-vaccination responses to emerging influenza variants. Recent observational studies also suggest prior vaccination may influence the performance of current seasonal vaccines.
[h=4]Methods.:[/h] To elucidate the effects of age and influenza pre-exposures on cross-reactivity of vaccination-induced human antibodies, we generated antigenic maps based on post-vaccination hemagglutination inhibition titers against representative H3 variants circulating during the 2015/16, 2014/15, and 2012/13 influenza seasons respectively.
[h=4]Results.:[/h] Antigenic maps determined using sera from subjects 18-64 and ≥65 years of age correlated well with each other but poorly with those determined using sera from children. Antigenic maps derived from human post-vaccination sera with H1 influenza pre-exposure also correlated poorly with those derived from sera with neither H1 nor type B influenza pre-exposure, and the correlation lessened considerably over time. In contrast, antigenic maps derived from human post-vaccination sera with only type B influenza pre-exposure consistently showed good correlation with those derived from sera with neither H1 nor type B influenza pre-exposure.
[h=4]Conclusions.:[/h] Our results suggest an age-specific difference in human post-vaccination responses. Our findings also suggest prior exposure to H1 or type B influenza may differentially affect cross-reactivity of vaccination-induced H3-specific hemagglutination inhibition antibody responses, and consequently might affect vaccine effectiveness. Our study highlights the need to study the impact of prior exposure on influenza vaccine performance.


[h=4]KEYWORDS:[/h] Antigenic Map; H3N2 Antibody Cross-reactivity; Prior Exposure; Seasonal Influenza Vaccine; Vaccine Strain Selection

PMID: 28369230 DOI: 10.1093/cid/cix269
 
Back
Top Bottom